Format

Send to

Choose Destination
Leukemia. 2018 Aug;32(8):1860-1865. doi: 10.1038/s41375-018-0130-0. Epub 2018 Apr 18.

Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia.

Garcia EG1,2,3,4, Iyer S1,2,3,4, Garcia SP1,2,3,4, Loontiens S5, Sadreyev RI1,4, Speleman F5, Langenau DM6,7,8,9.

Author information

1
Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.
2
Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.
3
Harvard Stem Cell Institute, Boston, MA, 02114, USA.
4
Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
5
Cancer Research Institute Ghent (CRIG) and Center for Medical Genetics, Ghent University, Ghent, Belgium.
6
Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA. dlangenau@mgh.harvard.edu.
7
Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA. dlangenau@mgh.harvard.edu.
8
Harvard Stem Cell Institute, Boston, MA, 02114, USA. dlangenau@mgh.harvard.edu.
9
Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA. dlangenau@mgh.harvard.edu.
PMID:
29749398
PMCID:
PMC6620784
DOI:
10.1038/s41375-018-0130-0
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center